| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050590102 |
| P356 | DOI | 10.1038/SJ.BJC.6690313 |
| P932 | PMC publication ID | 2363026 |
| P698 | PubMed publication ID | 10389970 |
| P5875 | ResearchGate publication ID | 12909190 |
| P2093 | author name string | J M Varley | |
| G McGown | |||
| J M Birch | |||
| L A James | |||
| M Thorncroft | |||
| E C Burt | |||
| P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| A cancer family syndrome in twenty-four kindreds | Q34177945 | ||
| Li-Fraumeni syndrome – a molecular and clinical review | Q34432117 | ||
| The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. | Q35250021 | ||
| Mutations and altered expression of p16INK4 in human cancer. | Q35892778 | ||
| The CDKN2A (p16) gene and human cancer. | Q36437816 | ||
| Cell-cycle regulators and cancer | Q40514881 | ||
| Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. | Q48164244 | ||
| Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families | Q57266910 | ||
| A study of the PTEN/MMAC1 gene in 136 breast cancer families | Q74268830 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9-10 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome | |
| P478 | volume | 80 |
| Q74333199 | A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla |
| Q42383055 | Does PTEN gene mutation play any role in Li-Fraumeni syndrome |
| Q34181585 | Germline TP53 mutations and Li-Fraumeni syndrome |
| Q48472181 | Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? |
| Q73305484 | Identification of a novel PTEN intronic deletion in Li-Fraumeni syndrome and its effect on RNA processing |
| Q22241780 | Li-fraumeni syndrome |
| Q72992667 | Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene |
| Q77785199 | The Li-Fraumeni syndrome |
| Q37147694 | The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype |
Search more.